Excelimmune Adds $12M
Woburn, Mass.-based biotech company Excelimmune Inc. has raised $12 million from an undisclosed investor to help it develop its infectious disease programs. Terms of the deal were not released. Formed in 2006, the company specializes in the development of recombinant polyclonal antibodies to create novel therapies for treating disease.
20 December 2011•2 mins read
